The use of quetiapine for treatment-resistant bipolar disorder: A case series

Annals of Clinical Psychiatry

Volumn 11, Issue 3, 1999, Pages 137-140

  Ghaemi, S Nassir ^a   Katzow, Jacob J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Atypical antipsychotics; Bipolar disorder; Drug therapy; Quetiapine

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ADULT; AKATHISIA; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERANCE; DRUG USE; FEMALE; HEADACHE; HUMAN; HYPOMANIA; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MOOD; OUTPATIENT; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; SCHIZOIDISM; SCHIZOPHRENIA; SEDATION; TREATMENT PLANNING; VOMITING; WEIGHT GAIN; XEROSTOMIA;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0032883516     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022307910520     Document Type: Article

References (28)

1. Calabrese JR, Kimmel SE, Woyshville MJ, et al.: Clozapine for treatment-refractory mania. American Journal of Psychiatry 1996; 153:759-764
2. Zarate CA, Tohen M, Baldessarini RJ: Clozapine in severe mood disorders. J Clinical Psychiatry 1995; 56:411-417
3. Frankenburg FR: Clozapine and bipolar disorder. J-Clin-Psychopharmacol 1993; 13(4):289-90
4. Naber D, RH, CP, HH: Clinical management of clozapine patients in relation to efficacy and side-effects. British Journal of Psychiatry 1992; 160(suppl 17):54-59
5. McElroy SL, Dessain EC, Pope HG, et al.: Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clinical Psychiatry 1991; 52:411-414
6. Banov MD, Zarate CA, Tohen M, et al.: Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clinical Psychiatry 1994; 55:295-300
7. Suppes T, McElroy SL, Gilbert J, Dessain EC, Cole JO: Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992; 32(3):270-280
8. Jacobsen FM: Risperidone in the treatment of affective illness and obsessive-compulsive disorder. Journal of Clinical Psychiatry 1995; 56:423-429
9. Tohen M, Zarate CA, Centorrino F, Hegary JI, Froeschl M, Zarate SB: Risperidone in the treatment of mania. Journal of Clinical Psychiatry 1996; 57:249-253
10. Ghaemi SN, Sachs GS, Baldassano C, Truman C: Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Canadian Journal of Psychiatry 1997; 42:196-199
11. Ghaemi SN, Sachs GS: Long-term risperidone treatment in bipolar disorder: 6 month follow-up. International Clinical Psychopharmacology 1998; 12:333-338
12. Dwight MM, Keck PE, Stanton SP, Strakowski SM, McElroy SL: Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder (letter). The Lancet 1994; 344:554-555
13. Sajatovic M, DiGiovanni SK, Bastani B, Hattab H, Ramirez LF: Risperidone therapy in treatment refractory acute bipolar and schizoaffective mania. Psychopharmacology Bulletin 1996; 32:55-61
14. Keck PE, Jr., Wilson DR, Strakowski SM, et al.: Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. Journal of Clinical Psychiatry 1995; 56:466-471
15. Singh AN, Catalan J: Safety of risperidone in patients with HIV and AIDS. New York: American Psychiatric Association: 1996
16. Gilmer WS, Ferrando SJ, Goldman JD: Risperidone in the treatment of psychiatric symptoms in patients with AIDS. 148th American Psychiatric Association Annual Meeting, Miami, Florida, 1995
17. Horne RL, Miller F: Use of risperidone in a private psychiatric practice. 148th American Psychiatric Association Annual Meeting, Miami, Florida, 1995
18. Schaffer CB, Schaffer LC: The use of risperidone in the treatment of bipolar disorder (letter). Journal of Clinical Psychiatry 1996; 57:136
19. Tohen M, Sanger TM, Tollefson GD, McElroy SL: Olanzapine versus haloperidol in the treatment of schizoaffective bipolar patients. 2nd international conference on bipolar disorder, Pittsburgh, Pennsylvania, 1997
20. Tohen M, Snger T, Tollefson G, McElroy S, Greatney M, Toma V: Olanzapine vs. placebo in the treatment of acute mania (abstract). American College of Neuropsychopharmacology, Waikoloa, Hawaii, 1997, December
21. McElroy S, Frye M, Denicoff K, et al.: Olanzapine in treatment-resistant bipolar disorder. Journal of Affective Disorders 1998; 49:119-122
22. Zarate CA, Narendran R, Tohen M, et al.: Clinical predictors of acute response with olanzapine in psychotic mood disorders. Journal of Clinical Psychiatry 1998; 59:24-28
23. Ghaemi SN, Lee-Cherry ER, Katzow JJ, Goodwin FK: Olanzapine treatment of mood disorders. American Psychiatric Association annual meeting, Toronto, Ontario, 1998
24. Sachs G, et al.: Comparison of atypical antipsychotics in the treatment of bipolar disorder. Collegium Internationale Neuropsychopharmacologicum, Scotland, 1998
25. Casey D: The relationship of pharmacology to side effects. Journal of Clinical Psychiatry 1997; 58(suppl 10):55-62
26. Chouinard G, Arnott W: Clinical review of risperidone. Canadian Journal of Psychiatry 1993; 38(suppl 3):S89-S95
27. Novac A: The use of atypical antipsychotics in rapid-cycling bipolar disorder. Annals of Clinical Psychiatry 1998; 10:107-111
28. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W: Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Research 1997; 73:159-171